Prophase Labs (PRPH) Stock Statistics & Valuation Metrics

Prophase Labs has a market cap or net worth of $15.45M. The enterprise value is $31.20M.

Prophase Labs has 41,541,206 shares outstanding. The number of shares has decreased by -2.65% in one year.

Prophase Labs’s return on equity (ROE) is -7.26 and return on invested capital (ROIC) is -120.09%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Prophase Labs had revenue of 6.77M and earned -53.36M in profits. Earnings per share was -2.43.

In the last 12 months, operating cash flow was -15.80M and capital expenditures -202.00K, giving a free cash flow of -15.77M billion.

Prophase Labs pays an annual dividend of $0.3, resulting in a dividend yield of ―

Prophase Labs upcoming earnings date is Aug 7, 2025, TBA (Confirmed).

Prophase Labs as a current ratio of 0.95, with Debt / Equity ratio of 92.65%

In the past 12 months, Prophase Labs has paid 7.20M in taxes.

Prophase Labs EV to EBITDA ratio is -1.19, with an EV/FCF ratio of -2.08.

Prophase Labs has $88.00K in cash and marketable securities with $14.01M in debt, giving a net cash position of $13.92M billion.

Gross margin is 17.71%, with operating margin of -570.59%, and net profit margin of -788.24%.

The average price target for Prophase Labs is $0.50, which is 11.43% higher than the current price. The consensus rating is Moderate Sell